Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$8.91 USD
-0.37 (-3.99%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $8.57 -0.34 (-3.82%) 7:48 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
12/09/2024
Time: -- |
9/2024 | $0.32 | 0.00% |
Earnings Summary
For their last quarter, Emergent Biosolutions (EBS) reported earnings of -$2.32 per share, missing the Zacks Consensus Estimate of -$0.97 per share. This reflects a negative earnings surprise of 139.18%. Look out for EBS's next earnings release expected on December 09, 2024. For the next earning release, we expect the company to report earnings of $0.32 per share, reflecting a year-over-year increase of 122.22%.
Earnings History
Price & Consensus
Zacks News for EBS
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services